Wikipedia

Yolonda L. Colson

(Redirected from Yolonda Lorig Colson)

Yolonda Lorig Colson is an American thoracic surgeon, working in Boston, who was the 103rd president and first female president of the American Association for Thoracic Surgery (AATS), succeeding Shaf Keshavjee, MD and preceding Lars G. Svensson, MD, PhD.[1][2] Colson is the Chief of the Division of Thoracic Surgery at Massachusetts General Hospital,[3] Hermes C. Grillo Professor in Thoracic Surgery, and Professor of Surgery at Harvard Medical School. Colson is an Officer and Exam Chair for the American Board of Thoracic Surgery.[4] She is also a collaborator of the Grinstaff Group.[5]

Yolonda L. Colson
Colson teaching intraoperatively at Massachusetts General Hospital
Colson (center) intraoperatively teaching
EducationMayo Medical School (MD)

University of Pittsburgh School of Medicine (PhD and surgery residency)

Harvard Medical School Brigham and Women's Hospital (fellowship in cardiothoracic surgery)
Known forFirst female president of the American Association for Thoracic Surgery
Medical career
ProfessionThoracic Surgeon
InstitutionsHarvard Medical School
Research
  • Polymer and nanoparticle drug delivery to prevent cancer recurrence
  • Methods to identify hidden tumor spreading to nearby lymph nodes

Education

edit

Colson completed her Bachelor of Science (B.S.) in Biomedical Engineering from Rensselaer Polytechnic Institute, Doctor of Medicine (M.D.) from Mayo Medical School, and Doctor of Philosophy (Ph.D.) and general surgery residency at the University of Pittsburgh School of Medicine.[6] She then completed a fellowship in cardiothoracic surgery at Brigham and Women's Hospital.

Grants

edit

Colson has been awarded many R29 and R01 NIH and NCI grants:

  • Biodegradable, Biocompatible Pressure Sensitive Adhesives (2022[7])
  • Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas (2022[8])
  • Optimization Of Nanoparticle Tumor-Localization And Drug-Loadingfor Treating Mesothelioma (2022,[9] 2021,[10] 2020[11])
  • Tumor Specific Delivery Of Verticillin A Overcomes Epigenetic Silencing Responsible For Drug Resistance (2022,[12] 2021,[13] 2020,[14] 2019,[15] 2018[16])
  • Superhydrophobic Drug Loaded Buttresses For Prevention Of Lung Tumor Recurrence (2022,[17] 2021,[18] 2020,[19] 2019[20])
  • Precise tumor targeting with logic CAR circuits (2022,[21] 2021[22])
  • Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma (2019,[23] 2018,[24] 2017,[25] 2016[26])
  • Flexible, Conformal, Polymeric Films for Lung Resection Margins (2014,[27] 2013,[28] 2012,[29] 2011[30])
  • Innovative Clinical Pathways in Lung Cancer Care for Vulnerable Populations (2012[31])
  • NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases (2011,[32] 2010,[33] 2009,[34] 2008[35])
  • Mechanism of Facilitating Cell-Mediated Tx Tolerance (2007,[36] 2006,[37] 2005,[38] 2004,[39][40] 2003[41])
  • Facilitating Cell Induced Tolerance In Organ Transplants (2001,[42] 2000,[43] 1999,[44] 1998,[45] 1997[46])

Colson also received over twenty AATS foundation grants.[1]

Awards and recognitions

edit
  • 103rd president of the American Association for Thoracic Surgery (AATS)[1]
  • George H.A. Clowes, Jr. Research Career Development Award from the American College of Surgeons (ACS) (2006-2011)[47]
  • Edward M. Kennedy Award for Health Care Innovation from CIMIT[4]
  • First recipient of Michele Kessler Leadership Award in Women's Health (2006)[48]
  • AATS Alton Ochsner Research Scholarship[49]
  • Above and Beyond Award, Employer Support of the Guard and Reserve, US (2009)[citation needed]
  • Maxwell Resident Career-Research Award (1998-1999)[citation needed]

In 2010 Colson was recognized by the Lung Cancer Alliance for her work "Out of the Shadows", a women's health policy and advocacy program regarding lung cancer in women.[50] In 2020 Colson was interviewed by CTSNet after she was elected as the Vice President of the AATS.[51] Colson is mentioned several Castle Connolly Medical publications.[52][53][54][55]

In 2020, she was elected to the National Academy of Medicine.[56]

Other accomplishments

edit

Colson is a co-inventor on six patents.

  • Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells, (2000).[57]
  • Films and particles, (2010).[58]
  • Films and particles, (2012).[59]
  • Films and particles, (2012).[60]
  • Compliant composites for application of drug-eluting coatings to tissue surfaces, (2014).[61]
  • Polymeric depots for localization of agent to biological sites, (2019).[62]

She founded the Women's Lung Cancer Forum.[63] She is the author of many journal articles and textbook chapters, including the text "Adult Chest Surgery".[64]

References

edit
  1. ^ a b c "Yolonda L. Colson Assumes Presidency of the American Association for..." AATS. Retrieved 2022-09-01.
  2. ^ "AATS Past..." The American Association for Thoracic Surgery | AATS. Retrieved 2023-06-01.
  3. ^ "Member News: Spring 2019 | STS". www.sts.org. Retrieved 2022-09-05.
  4. ^ a b Lawton, Jennifer S (2021). "A historic event: The first female officer of the American Association for Thoracic Surgery". Journal of Thoracic and Cardiovascular Surgery. 161 (3): 730–732. doi:10.1016/j.jtcvs.2020.06.079. PMC 7335416. PMID 32741627.
  5. ^ "Collaborators". THE GRINSTAFF GROUP. Retrieved 2022-09-05.
  6. ^ "Yolonda Colson, MD, PhD - Thoracic Surgery". Massachusetts General Hospital. Retrieved 2022-09-01.
  7. ^ "Biodegradable, Biocompatible Pressure Sensitive Adhesives". 2022.
  8. ^ "Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas". 2022.
  9. ^ "OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA". 2022.
  10. ^ "OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA". 2021.
  11. ^ "OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA". 2020.
  12. ^ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2022.
  13. ^ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2021.
  14. ^ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2020.
  15. ^ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2019.
  16. ^ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2018.
  17. ^ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE". 2022.
  18. ^ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE". 2021.
  19. ^ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE". 2020.
  20. ^ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE". 2019.
  21. ^ "Precise tumor targeting with logic CAR circuits". 2022.
  22. ^ "Precise tumor targeting with logic CAR circuits". 2021.
  23. ^ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2019.
  24. ^ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2018.
  25. ^ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2017.
  26. ^ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2016.
  27. ^ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2014.
  28. ^ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2013.
  29. ^ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2012.
  30. ^ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2011.
  31. ^ "Innovative Clinical Pathways in Lung Cancer Care for Vulnerable Populations". 2012.
  32. ^ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2011.
  33. ^ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2010.
  34. ^ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2009.
  35. ^ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2008.
  36. ^ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2007.
  37. ^ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2006.
  38. ^ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2005.
  39. ^ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2004.
  40. ^ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2004.
  41. ^ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2003.
  42. ^ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 2001.
  43. ^ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 2000.
  44. ^ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 1999.
  45. ^ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 1998.
  46. ^ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 1997.
  47. ^ "Past ACS Scholarship Awardees". ACS. Retrieved 2022-09-12.
  48. ^ "BWH Bulletin". www.bwhpublicationsarchives.org. Retrieved 2022-09-17.
  49. ^ "AATS Research Scholarship Awardees". AATS. Retrieved 2022-09-17.
  50. ^ Alliance, Lung Cancer. "Lung Cancer Alliance Applauds New Report Bringing Lung Cancer in Women Out of the Shadows". www.prnewswire.com (Press release). Retrieved 2022-09-05.
  51. ^ Antonoff, Mara (2022). "Dr Yolonda Colson, Leading the Future of CT Surgery". doi:10.25373/ctsnet.12631886. {{cite journal}}: Cite journal requires |journal= (help)
  52. ^ "Dr. Yolonda L. Colson - Thoracic & Cardiac Surgery - Boston, MA". Castle Connolly. Retrieved 2022-09-17.
  53. ^ America's top doctors : the best in American medicine : America's trusted source for identifying top doctors. Castle Connolly Medical Ltd (12th ed.). New York, N.Y.: Castle Connolly. 2013. ISBN 978-1-883769-63-5. OCLC 812781032.{{cite book}}: CS1 maint: others (link)
  54. ^ America's top doctors : the best in American medicine : America's trusted source for identifying top doctors. Castle Connolly Medical Ltd (13th ed.). New York, N.Y.: Castle Connolly. 2014. ISBN 978-1-883769-68-0. OCLC 871345615.{{cite book}}: CS1 maint: others (link)
  55. ^ America's top doctors : America's trusted source for identifying top doctors. Castle Connolly Medical Ltd (14th ed.). New York. 2015. ISBN 978-1-935036-01-2. OCLC 903146902.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  56. ^ "Yolonda L. Colson, M.D., Ph.D." National Academy of Medicine.
  57. ^ US 6013519, Ildstad, Suzanne T.; Kaufman, Christina & Colson, Yolanda, "Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells", published 2000-01-11, assigned to University of Pittsburgh 
  58. ^ US 7671095, Colson, Yolonda; Azouz, Solomon & Grinstaff, Mark et al., "Films and particles", published 2010-03-02, assigned to The Trustees of Boston University and Brigham and Women's Hospital Inc. 
  59. ^ US 8334324, Colson, Yolonda L.; Azouz, Solomon & Grinstaff, Mark W. et al., "Films and particles", published 2012-12-18, assigned to The Trustees of Boston University and Brigham and Women's Hospital Inc. 
  60. ^ US 8338492, Colson, Yolonda L.; Azouz, Solomon & Grinstaff, Mark W. et al., "Films and particles", published 2012-12-25, assigned to The Trustees of Boston University and Brigham and Women's Hospital Inc. 
  61. ^ US 8795707, Wolinsky, Jesse; Grinstaff, Mark W. & Colson, Yolonda L., "Compliant composites for application of drug-eluting coatings to tissue surfaces", published 2014-08-05, assigned to The Trustees of Boston University and Brigham and Women's Hospital Inc. 
  62. ^ US 10251841, Grinstaff, Mark W.; Colby, Aaron H. & Colson, Yolonda, "Polymeric depots for localization of agent to biological sites", published 2019-04-09, assigned to The Trustees of Boston University and Brigham and Women's Hospital Inc. 
  63. ^ "Women Lung Cancer Forum - Brigham and Women's Hospital". www.brighamandwomens.org. Retrieved 2022-09-12.
  64. ^ Adult chest surgery. David J. Sugarbaker, Raphael Bueno, Yolonda L. Colson, Michael T. Jaklitsch, Mark Krasna, Steven J. Mentzer (Second ed.). New York. 2015. ISBN 978-0-07-178189-3. OCLC 883749093.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Yolonda_L._Colson&oldid=1253260992"